Biogen reported $7.28B in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
ALKERMES ALKS:US $ 294.54M 0.63M
Amgen AMGN:US $ 36522M 332M
Bayer BAYN:GR € 44634M 2087M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Eli Lilly And LLY:US $ 16813.8M 305M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 70.35M 0.42M
Moderna Inc MRNA:US 762M 44M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 31031M 244M
Ptc Therapeutics PTCT:US $ 1207.54M 10.46M
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 22.08B 835M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 34.19M 0.01M